We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
-23.29%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
AUM
$278M
AUM Growth
-$221M
Cap. Flow
-$143M
Cap. Flow %
-51.39%
Top 10 Hldgs %
66.61%
Holding
136
New
1
Increased
12
Reduced
8
Closed
64

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.12%
2 Healthcare 23.46%
3 Consumer Staples 7.13%
4 Technology 6.67%
5 Materials 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRI
1
DELISTED
Everi Holdings
EVRI
$23.1M 8.28%
1,413,572
+126,513
+10% +$2.23M
TPB icon
2
Turning Point Brands
TPB
$1.56B
$19.9M 7.13%
732,032
+81,354
+13% +$2.39M
DIN icon
3
Dine Brands
DIN
$458M
$19.6M 7.03%
300,689
+31,000
+11% +$2.21M
SUM
4
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$17.1M 6.16%
748,529
+20,340
+3% +$540K
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$16.8M 6.04%
210,961
+25,908
+14% +$2.45M
THC icon
6
Tenet Healthcare
THC
$22.6B
$16.5M 5.94%
314,550
+87,891
+39% +$6.12M
ETWO
7
DELISTED
E2open Parent Holdings
ETWO
$15.7M 5.64%
2,016,283
+200,000
+11% +$1.61M
BLMN icon
8
Bloomin' Brands
BLMN
$736M
$15.5M 5.57%
933,447
-74,727
-7% -$1.52M
CZR icon
9
Caesars Entertainment
CZR
$6.1B
$14.9M 5.36%
389,457
+119,325
+44% +$6.65M
INSE icon
10
Inspired Entertainment
INSE
$188M
$14.8M 5.33%
1,724,450
-55,433
-3% -$565K
CYH icon
11
Community Health Systems
CYH
$393M
$13.9M 4.98%
3,693,594
+440,725
+14% +$3.1M
HOV icon
12
Hovnanian Enterprises
HOV
$800M
$12.6M 4.54%
295,147
+27,350
+10% +$1.33M
THC icon
13
CALL
Tenet Healthcare
THC
$22.6B
$10.5M 3.78%
+200,000
New +$13.9M
BKEP
14
DELISTED
Blueknight Energy Partners L.P.
BKEP
$8.85M 3.18%
1,956,842
-2,000,092
-51% -$8.52M
AMRN
15
Amarin Corp
AMRN
$293M
$8.66M 3.11%
290,473
+73,249
+34% +$3.16M
FENC icon
16
Fennec Pharmaceuticals
FENC
$345M
$6.84M 2.46%
1,210,638
HTZ icon
17
Hertz
HTZ
$556M
$4.46M 1.6%
281,506
-21,846
-7% -$431K
PRVB
18
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.49M 0.89%
622,568
+100,000
+19% +$474K
AWRE icon
19
Aware
AWRE
$24.2M
$2.16M 0.78%
907,047
FWAC
20
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$1.42M 0.51%
145,903
ORIA
21
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$1.24M 0.45%
127,665
FMIV
22
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$1.2M 0.43%
122,952
PTOC
23
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$713K 0.26%
72,943
-200,009
-73% -$1.95M
MACC
24
DELISTED
Mission Advancement Corp.
MACC
$610K 0.22%
62,400
-10,552
-14% -$103K
ARYE
25
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$524K 0.19%
53,958

Similar funds

DG Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, DG Capital Management held 136 positions worth $278M, down 44% from $500M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

DG Capital Management withdrew a net $143M in Q2 2022, closing 64 positions and reducing 8 holdings. Its most notable exit was United Therapeutics, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, DG Capital Management added an estimated $6.65M to Caesars Entertainment.

  • DG Capital Management added most to Caesars Entertainment in Q2 2022, an estimated $6.65M increase.
  • DG Capital Management's biggest Q2 2022 reduction was Blueknight Energy Partners L.P., cutting an estimated $8.52M.
  • DG Capital Management fully exited United Therapeutics in Q2 2022, selling an estimated $19.5M.
  • DG Capital Management's ten largest holdings make up 67% of its $278M portfolio in Q2 2022.
  • DG Capital Management opened 1 new position and closed 64 in Q2 2022.
  • DG Capital Management's portfolio value fell 44% quarter-over-quarter to $278M.

Based on DG Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.